Frontlight ResearchEarly access
Trial site
Szpital Wojewodzki w Opolu
- 3running trials
- 2closed trials
The trials here
What the 5 trials at this site are about, from their registry records.
- Conditions
- Acute myeloid leukaemia2 trials
- Chronic myeloid leukaemia1 trial
- Diffuse large B-cell lymphoma1 trial
- Hodgkin lymphoma1 trial
- Myelodysplastic syndromes1 trial
- Myeloproliferative neoplasms1 trial
- Phase
- Phase 33 trials
- Phase 1/21 trial
- Phase 21 trial
- Status
- Active, not recruiting2 trials
- Completed2 trials
- Recruiting1 trial
- Lead sponsor
- Hoffmann-La Roche1 trial
- Kartos Therapeutics, Inc.1 trial
- Polska Grupa Badawcza Chloniakow1 trial
- Sellas Life Sciences Group1 trial
- Takeda1 trial
Running trials
Recruiting
Active, not recruiting
Active, not recruiting
KRT-232 Compared to Ruxolitinib in Patients With Phlebotomy-Dependent Polycythemia Vera
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Hodgkin lymphoma1 recruiting
Closed trials
Completed
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026